Pfizer Settles Zantac Cancer Lawsuits for $250 Million

Описание: Pfizer will pay up to $250 million to settle over 10,000 U.S. lawsuits concerning cancer risks linked to its discontinued heartburn drug, Zantac. The settlement, revealed in a Delaware court filing, aims to reduce Pfizer's potential liability. First approved in 1983, Zantac became a top-selling drug but was pulled from the market in 2020 due to cancer-causing NDMA found in samples.

Open your MEXEM account now: https://bit.ly/3x9nybw

Find us:
https://www.mexem.com
  / mexembroker  
  / mexemeurope  

This material has been prepared without taking into account any particular recipient’s investment objectives or financial situation and has not been prepared in accordance with the legal and regulatory requirements to promote independent research. This communication is for information and education purposes only and should not be taken as investment advice, a personal recommendation, or an offer of, or solicitation to buy or sell, any financial instruments. Any references to past or future performance of a financial instrument, index or a packaged investment product are not, and should not be taken as, a reliable indicator of future results. MEXEM makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication.

MEXEM Ltd is a European broker regulated by CySEC, license No. 325/17.
All investments involve risks, including the possible loss of capital.